Cargando...
MGMT promoter methylation in Peruvian patients with glioblastoma
PURPOSE: O(6)-methylguanine–DNA methyltransferase (MGMT) promoter methylation predicts the outcome and response to alkylating chemotherapy in glioblastoma. The aim of this study is to evaluate the prevalence of MGMT methylation in Peruvian glioblastoma cases. PATIENTS AND METHODS: We evaluated retro...
Guardado en:
| Publicado en: | Ecancermedicalscience |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Cancer Intelligence
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5834313/ https://ncbi.nlm.nih.gov/pubmed/29515653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2018.812 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|